Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,259Revenue $M778Net Margin (%)10.9Altman Z-Score6.0
Enterprise Value $M3,117EPS $1.2Operating Margin %10.9Piotroski F-Score2
P/E(ttm)38.6Beneish M-Score--Pre-tax Margin (%)13.5Higher ROA y-yN
Price/Book3.610-y EBITDA Growth Rate %--Quick Ratio2.1Cash flow > EarningsN
Price/Sales4.35-y EBITDA Growth Rate %16.4Current Ratio2.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-15.2ROA % (ttm)6.8Higher Current Ratio y-yN
Dividend Yield %--PEG2.4ROE % (ttm)10.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M71.0ROIC % (ttm)10.8Gross Margin Increase y-yN

Gurus Latest Trades with WX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
WXFirst Eagle Investment 2015-09-30 Sold Out $37.97 - $44.1
($42.2)
$ 45.909%Sold Out0
WXMario Gabelli 2015-09-30 Add$37.97 - $44.1
($42.2)
$ 45.909%Add 13.10%61,300
WXFirst Eagle Investment 2015-06-30 Buy $38.2 - $45.18
($42.12)
$ 45.909%New holding10,000
WXMario Gabelli 2015-06-30 Reduce$38.2 - $45.18
($42.12)
$ 45.909%Reduce -5.24%54,200
WXRon Baron 2015-03-31 Add0.01%$32.73 - $41.7
($38.52)
$ 45.9019%Add 35.79%341,500
WXRon Baron 2014-12-31 Add0.01%$32.91 - $38.69
($35.32)
$ 45.9030%Add 24.81%251,500
WXRon Baron 2014-03-31 Add0.01%$32.58 - $39.86
($36.74)
$ 45.9025%Add 25.90%210,500
WXJulian Robertson 2013-12-31 Sold Out -2.4%$26.52 - $38
($31.52)
$ 45.9046%Sold Out0
WXRon Baron 2013-12-31 Add0.02%$26.52 - $38
($31.52)
$ 45.9046%Add 883.53%167,200
WXMario Gabelli 2013-12-31 Reduce$26.52 - $38
($31.52)
$ 45.9046%Reduce -24.71%65,200
WXJulian Robertson 2013-09-30 Reduce-0.85%$20.23 - $28.48
($23.68)
$ 45.9094%Reduce -35.37%576,218
WXMario Gabelli 2013-09-30 Reduce$20.23 - $28.48
($23.68)
$ 45.9094%Reduce -26.05%86,600
WXRon Baron 2013-09-30 Add$20.23 - $28.48
($23.68)
$ 45.9094%Add 54.55%17,000
WXJulian Robertson 2013-06-30 Reduce-0.34%$16.94 - $21.54
($19.52)
$ 45.90135%Reduce -13.99%891,618
WXRon Baron 2013-06-30 Buy $16.94 - $21.54
($19.52)
$ 45.90135%New holding11,000
WXJulian Robertson 2012-06-30 Add0.28%$13.37 - $14.84
($14.21)
$ 45.90223%Add 6.51%1,154,418
WXJulian Robertson 2012-03-31 Reduce-1.67%$11.43 - $15.39
($12.73)
$ 45.90261%Reduce -24.88%1,083,818
WXMario Gabelli 2011-12-31 Reduce-0.01%$10.78 - $13.92
($11.9)
$ 45.90286%Reduce -28.82%250,200
WXJulian Robertson 2011-09-30 Add1.9%$11.56 - $17.26
($14.19)
$ 45.90223%Add 38.60%1,442,806
WXGeorge Soros 2011-06-30 Sold Out $16 - $18.89
($17.29)
$ 45.90165%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

WX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


WX: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about WX :

Quarterly/Annual Reports about WX:

    News about WX:

    Articles On GuruFocus.com
    Matthews Pacific Tiger Fund Adds 2 New Stocks to Portfolio May 05 2015 
    Baron Funds Comments on WuXi PharmaTech Feb 24 2014 
    Columbia Management's Top 5 New Buys Amid Buoyant Outlook Aug 12 2013 
    Stocks That Are Cheaper Than Julian Robertson Bought Jan 06 2012 
    Stocks That Julian Robertson Keeps Buying Dec 23 2011 
    Julian Robertson’s "smart idea, grounded on exhaustive research, followed by a big bet" Jun 24 2011 
    Julian Robertson’s Tiger Management Q1 Portfolio Update May 16 2011 
    Tiger Management Buys WX, CVC, THRX, Sells Apple Inc., Google Inc., Ebay Inc. Nov 15 2010 

    More From Other Websites
    AstraZeneca Invests in China, To Buy Respiratory Business Dec 17 2015
    WuXi and AstraZeneca Form Strategic Alliance to Expedite Development of AstraZeneca's Innovative... Dec 16 2015
    WuXi PharmaTech Presents 2015 Life Science and Chemistry Awards Dec 13 2015
    WuXi PharmaTech (Cayman) Inc. Announces Completion of Going Private Transaction Dec 10 2015
    WuXi PharmaTech (Cayman) Inc. Announces Completion of Going Private Transaction Dec 10 2015
    WUXI PHARMATECH (CAYMAN) INC. Financials Dec 08 2015
    WuXi PharmaTech and PRA Health Sciences Restructure Relationship in China Dec 07 2015
    WuXi PharmaTech and PRA Health Sciences Restructure Relationship in China Dec 07 2015
    Dr. Ge Li Receives Executive of the Year Award from SCRIP Dec 07 2015
    Is Royal Gold, Inc USA) (RGLD) A Good Stock To Buy? Dec 02 2015
    WuXi PharmaTech Announces Shareholders' Approval of Merger Agreement Nov 24 2015
    Do Hedge Funds Love WuXi PharmaTech (Cayman) Inc. (ADR) (WX)? Nov 24 2015
    The State Of Chinese Company Take-Private Offers: A Look At WuXi PharmaTech Nov 19 2015
    Wuxi PharmaTech (Cayman) Inc. Earnings Q3, 2015 Nov 18 2015
    Genomics England Contracts With WuXi NextCODE as Clinical Interpretation Partner in Both Rare... Nov 12 2015
    Genomics England Contracts with WuXi NextCODE as Clinical Interpretation Partner in both Rare... Nov 12 2015
    Lion Biotechnologies Announces Agreement with WuXi AppTec to Increase TIL Manufacturing Capacity Nov 11 2015
    ISS and Glass Lewis Recommend that WuXi PharmaTech Shareholders Vote "FOR" the Proposed... Nov 11 2015
    ISS and Glass Lewis Recommend that WuXi PharmaTech Shareholders Vote "FOR" the Proposed... Nov 11 2015
    WuXi PharmaTech and Lilly Announce Strategic Collaboration to Develop Novel Therapeutic in China Nov 10 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK